Songyoung Kim has over 21 years of experience in the pharmaceutical process development and manufacturing industry. He has been responsible for DSPs, process characterization, and tech transfer of biosimilar products and new drugs for biotech companies. He joined Samsung Biologics in 2023 as a principal scientist and is focusing on development for downstream manufacturing.
